SCHEMBL20897966

SCHEMBL20897966

C[SiH](C)C(C)(C)COCCc1c(Cl)ccnc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20897968 0.74 DUT (0.32) —
SCHEMBL21355870 0.74 — —
SCHEMBL20607538 0.70 — —
SCHEMBL21356175 0.70 — —
SCHEMBL2472169 0.68 TAAR1 (0.38) —
SCHEMBL21356241 0.68 NOS3 (0.33) —
SCHEMBL21355916 0.68 — —
SCHEMBL20897958 0.67 RECQL (0.33) —
SCHEMBL460117 0.67 — —
SCHEMBL5240508 0.67 KDM4E (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019072978-A1 MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS Basilea Pharmaceutica International AG (CH) 2019-04-18 — — WO disclosed
Send feedback